115 related articles for article (PubMed ID: 38506035)
1. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract][Full Text] [Related]
2. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
Guan X; Gu S; Yuan M; Zheng X; Wu J
Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E.
Zhang Y; Tie Q; Bao Z; Shao Z; Zhang L
Comput Math Methods Med; 2021; 2021():6468405. PubMed ID: 34812269
[TBL] [Abstract][Full Text] [Related]
6. N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation.
Yang J; Yu H; Shen M; Wei W; Xia L; Zhao P
Cancer Sci; 2014 Feb; 105(2):219-27. PubMed ID: 24262005
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
Lu P; Jiang Y; Xia Z
Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
9. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin.
Bollaert E; Claus M; Vandewalle V; Lenglez S; Essaghir A; Demoulin JB; Havelange V
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068078
[TBL] [Abstract][Full Text] [Related]
10. miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4.
Deng J; Wang H; Liang Y; Zhao L; Li Y; Yan Y; Zhao H; Zhang X; Zou F
Cell Signal; 2023 Jan; 101():110517. PubMed ID: 36332797
[TBL] [Abstract][Full Text] [Related]
11. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.
Xu K; Zhan Y; Yuan Z; Qiu Y; Wang H; Fan G; Wang J; Li W; Cao Y; Shen X; Zhang J; Liang X; Yin P
Mol Ther; 2019 Oct; 27(10):1810-1824. PubMed ID: 31208913
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells.
Jin Y; Wang H; Zhu Y; Feng H; Wang G; Wang S
Eur J Pharmacol; 2020 Jul; 878():173105. PubMed ID: 32278855
[TBL] [Abstract][Full Text] [Related]
14. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
[TBL] [Abstract][Full Text] [Related]
15. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
16. Interactions Between
Wang S; Cheng M; Zheng X; Zheng L; Liu H; Lu J; Liu Y; Chen W
Onco Targets Ther; 2020; 13():13159-13170. PubMed ID: 33380806
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma.
Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F
World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871
[TBL] [Abstract][Full Text] [Related]
18. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
Yao Y; Zhang C; Xiong Y; Han B; Gao X; Wang S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1022-1029. PubMed ID: 34308851
[TBL] [Abstract][Full Text] [Related]
19. MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1.
Xia M; Sheng L; Qu W; Xue X; Chen H; Zheng G; Chen W
World J Surg Oncol; 2021 Jun; 19(1):174. PubMed ID: 34127010
[TBL] [Abstract][Full Text] [Related]
20.
Yang J; Jiang X; Chen Y; Teng L
Discov Med; 2023 Dec; 35(179):1167-1176. PubMed ID: 38058082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
